glp 1 development history Historical timeline of GLP-1 biology, receptor agonist discovery, and GLP-1 | Summary

Cardiovascular Benefits: Some studies suggest potential heart-related advantages, such as reduced risk of major adverse cardiovascular events

Rinaman explained that when GLP-1R agonist drugs are given systemically, they are not recruiting the central GLP-1 endogenous neurons but are accessing a subset of the receptors

These symptoms usually go away within weeks as the body learns to use ketones for fuel, unlike GLP-1 medication effects

Practical Use, Safety, and Drug Administration Practical implementation of GLP-1 receptor agonist therapy requires careful consideration of administration routes, side effect management, and safety constraints for optimal cardiovascular benefit delivery